Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Aditya Birla Health bets on wellness incentives to improve claims ratios
Aditya Birla Health wants to reward healthier customers, nudge those on the edge to be more consistent, and, lastly, intervene with high-risk customers to help them manage their health.
Unique Picks: 6 stocks held by only one MF scheme in April, falling up to 40% in CY26
An analysis of mutual fund portfolios revealed 29 stocks held exclusively by single schemes, with most underperforming in CY26. However, Satin Creditcare Network, Rossell Techsys, and Amanta Healthcare bucked the trend, delivering strong returns. Brooks Laboratories and EFC (I) were among those experiencing significant declines.
Sensex Today | Nifty 50 | Stock Market Live Updates: Sensex tumbles over 700 pts, Nifty below 24,000; con... - The Economic Times
Sensex Today | Nifty 50 | Stock Market Live Updates: Sensex tumbles over 700 pts, Nifty below 24,000; con...The Economic TimesWhy is market falling today? Sensex crashes 1,100 points, Nifty below 23,900. 6 key factorsThe Economic TimesStock market crashes today: Sensex falls 700 points, Nifty50 trades below 24,000 oil prices jump amid Middle East tensionsThe Times of IndiaSensex Today | Stock Market Live: Sensex pares losses but down 750 points, Nifty near 24,000; PSU bank stocks dragMoneycontrol.comSensex today | Stock Market Live: Sensex down 830 pts, Nifty falls 220 pts to 23,954.95; Tata Consumer, Max Healthcare top gainersBusinessLineStock Market Crash News Today Live Updates: Nifty Falls Below 23,900, Sensex Slides 1,000 Points; Vodafone Idea Shares Surge 8%NDTV ProfitSensex crashes 1,000 points: Why is the stock market falling today?India TodayNifty 50, Sensex prediction today: Check how Indian stock market is expected to trade on 11 MayMSNSensex crashes almost 1,200 points; investors lose ₹5 lakh crore: Key factors behind stock market crash explainedMint
Q4 Results This Week: Bharti Airtel, HPCL, Dixon, among 200 companies reporting numbers
As many as 200 companies, including Nifty 50 names such as Bharti Airtel, Cipla, JSW Steel and Power Grid, and multiple F&O and cash market names such as UPL, Canara Bank, Indian Hotels etc. will be reporting their March quarter results this week. Here's a look at the complete list:
Biosimilar ramp-up to drive growth for Biocon in FY27
Recently launched biosimilars across markets have begun scaling up and will gather momentum through the year, particularly in the second half of FY27, the company's top executive said
Sun Pharma, 5 stocks hit 52-week highs, rally up to 25% in a month
Sensex surged 940 points as six BSE 100 stocks hit 52-week highs, signalling strong bullish momentum. Stocks like Adani Ports, Nestle India and Sun Pharma led gains, supported by solid monthly performance and positive investor sentiment in a rising market
Ruchit Jain of Motilal Oswal suggests Granules India, Nippon Life, and SRF shares to buy for the short term
The Nifty 50 and Sensex increased on May 6, supported by a government credit guarantee scheme for businesses. Investor sentiment improved due to positive earnings reports and falling oil prices, suggesting resilience in markets despite recent challenges.
Biocon among 5 stocks showing bullish RSI upswing
Five stocks from the Nifty500 universe were flagged in the RSI Trending Up scan on May 5 after gaining over 4%. The indicator turned positive as RSI crossed above 50 from lower levels, signalling improving momentum, strengthening sentiment, and potential short-term buying opportunities in select stocks.
Aditya Birla Capital Q4 FY26 Results | Wockhardt Q4 FY26 Results | Top Buzzing Stocks Today - Equitymaster
Aditya Birla Capital Q4 FY26 Results | Wockhardt Q4 FY26 Results | Top Buzzing Stocks TodayEquitymaster
Aditya Birla Capital Q4 FY26 Results | Wockhardt Q4 FY26 Results | Top Buzzing Stocks Today - Equitymaster
Aditya Birla Capital Q4 FY26 Results | Wockhardt Q4 FY26 Results | Top Buzzing Stocks TodayEquitymaster
Emcure eyes India growth, global deals amid strong demand
Emcure Pharmaceuticals is boosting domestic expansion, R&D, and manufacturing. The company is also exploring acquisition opportunities in India and internationally. New products are expected to drive significant growth. Emcure's partnership with Novo Nordisk for GLP-1 therapies and a pipeline of complex injectables will support future momentum.
Emcure Pharma Q4 Results: Stock slips from 52-week high despite revenue, margin growth
Emcure Pharma posts 29% profit growth and 17% revenue rise in Q4FY26; stock falls over 5% after hitting a 52-week high of ₹1,830, despite strong international business momentum and margin gains.